Delivery Order SPE2DB22D1106-SPE2DB25FEUE1
- Not listed
- The Defense Logistics Agency awarded a $1,427.76 firm fixed price delivery order to AmerisourceBergen Drug Corp on December 10, 2025, for the supply of Clindamycin (pediatric) 75 mg/5 ml in 100 ml quantities, with a completion date of December 11, 2025. This non-competitive delivery order was placed against AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical support vehicle that extends through December...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Clindamycin (Pediatric) 75 mg/5 mL in 100 mL quantities, valued at $1,283.69. This non-set-aside, competitively awarded contract operates under a firm fixed-price arrangement with an ultimate completion date of August 22, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a single transaction...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on October 14, 2025, for the supply of Clindamycin PH 900 mg/6 ml vials totaling $1,242.18 under a firm fixed-price arrangement. This non-set-aside competitive award is scheduled for completion by October 15, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 18, 2025, for the supply of Clindamycin PH 1% Solution in 60ml quantities, valued at $2,454.60 with completion targeted for November 19, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a single transaction under...
- The Defense Logistics Agency awarded a delivery order valued at $4,495.87 to AmerisourceBergen Drug Corp on August 6, 2025, for the supply of Clindamycin HCL 150 mg capsules (100-count units). This is a firm fixed-price delivery order with an ultimate completion date of August 7, 2025, and represents a non-competitive set-aside award. The product will be supplied from AmerisourceBergen's Conshohocken, Pennsylvania facility, where the company maintains its corporate headquarters. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at approximately $643 to Amerisourcebergen Drug Corporation for clindamycin pediatric solution. The firm fixed price order is to supply 100mL bottles of the antibiotic medication for performance at the contractor's facility in Conshohocken, Pennsylvania by August 9, 2023. No additional details were provided regarding the original solicitation requirements or whether this delivery order was placed against an existing DLA contract...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Clindamycin PH 900 mg/6 ml vials with a ceiling value of $17,867.22. This firm fixed-price delivery order, which is not set-aside, will be performed at the vendor's Corporate Office in Conshohocken, Pennsylvania, with an ultimate completion date of July 23, 2025. The contract represents a routine pharmaceutical procurement under the defense medical...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a $2,321.16 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Clindamycin 60ML on November 10, 2025, with an ultimate completion date of November 12, 2025. This non-competitive delivery order represents a routine pharmaceutical procurement executed under AmerisourceBergen's existing indefinite delivery contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The...
- The Defense Logistics Agency awarded a $1,829.11 delivery order to AmerisourceBergen Drug Corp for Clindamycin Palmitate, an antibiotic pharmaceutical product. This firm fixed price delivery order, issued on December 5, 2025, is scheduled for completion by January 5, 2026, with performance taking place at the contractor's corporate office in Conshohocken, Pennsylvania. The award represents a non-competitive set-aside arrangement, reflecting AmerisourceBergen's established position as a...
- The Defense Logistics Agency awarded a $474,720 firm fixed price delivery order to Amerisourcebergen Drug Corporation for clindamycin pediatric solution. Under this contract, Amerisourcebergen will deliver 100mL bottles of 75mg/5mL clindamycin solution to a location in Conshohocken, Pennsylvania by September 25, 2023. The Defense Logistics Agency manages the Department of Defense's global supply chain and is likely procuring this antibiotic solution to support treatment of pediatric patients...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB25FEUE1Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 20, 2025, for the supply of Clindamycin (Pediatric) 75 mg/5 mL in 100 mL quantities, with a ceiling value of $1,743.23. This contract is structured as a firm fixed price delivery order with an ultimate completion date of June 23, 2025, and was competitively awarded without set-aside provisions. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.99 billion prime vendor agreement running through December 2026 that supports pharmaceutical procurement across military healthcare systems globally. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical supply needs across the Department of Defense and related healthcare systems. The company's extensive federal contract portfolio demonstrates its capability to deliver a comprehensive range of pharmaceutical products, including antibiotics, specialty medications, vaccines, and medical supplies across multiple therapeutic domains. This clindamycin pediatric formulation delivery aligns with the company's established role as a primary pharmaceutical supplier supporting military healthcare operations and the Defense Health Agency's medical supply chain requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 6/20/25 |